Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 1, 2010 (rev. 1)

Premium

GenomeQuest has appointed Richard Wilson to its science advisory board.

Wilson is a professor of genetics and director of the Genome Center at Washington University School of Medicine. His research focuses on using genome sequencing and analysis technology to improve diagnosis and treatment of cancer and other human diseases.


Integromics, a data management and analysis software company, has appointed Michael McManus as its president and CEO

Prior to joining Integromics, McManus led GenomeQuest’s corporate marketing, strategic alliances, product marketing, and product development efforts. He has also served as vice president of business development for the BioSciences Group of Fujitsu Computer Systems, and as vice president of marketing and business development at CambridgeSoft.

McManus will lead Integromics' efforts to expand its customer base, with a particular focus on proteomics and on further developing the company's activity in the US and Asian markets.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.